Literature DB >> 16616109

DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma-irradiation and N-methyl-N-nitrosourea.

Hyun-Mi Kang1, Ja-June Jang, Cordelia Langford, Seung-Hun Shin, Seon-Yang Park, Yeun-Jun Chung.   

Abstract

The genetic mechanism for the development and progression of a lymphoma is unclear. This study investigated the alterations in the DNA copy number and the expression profiles of the genes located in the altered regions in mouse thymic lymphomas that were induced by two mutagens, gamma-irradiation and N-methyl-N-nitrosourea (MNU). Microarray-based comparative genomic hybridization was used to precisely delineate the boundaries of the altered region. The copy number gains of chromosomes 4 and 5 were observed only in the radiation-induced lymphomas, and gains of chromosomes 10 and 14 were observed only in the MNU-induced lymphomas. Regional copy number losses in chromosomes 11, 16, and 19 appeared frequently in the radiation-induced lymphomas. The cancer-related genes Pten, Ikaros/Znfn1a1, Ercc4, and Top3b were located in the minimal deletion regions. In particular, the expression levels of the Pten, Top3b, and Ikaros genes were downregulated in both lymphoma groups, but the expression level of Ercc4 was downregulated only in the MNU group. This study also examined the expression levels of Sparc, Cxcl1, and Myc (synonym: c-Myc), which are located in the copy number gained chromosomes. Sparc was upregulated specifically in the radiation group, and Cxcl1 in the MNU group. c-Myc was upregulated in both groups. There was limited correlation between the DNA copy number profiles and the expression of the cancer-related genes in mouse lymphomagenesis. The chromosome aberrations and novel expression profiles of the cancer-related genes within the altered regions may provide important clues to the genetic mechanism for the development of lymphoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616109     DOI: 10.1016/j.cancergencyto.2005.08.002

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Role of Ikaros in T-cell acute lymphoblastic leukemia.

Authors:  Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

2.  Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy.

Authors:  Benjamin J Blyth; Shizuko Kakinuma; Masaaki Sunaoshi; Yoshiko Amasaki; Shinobu Hirano-Sakairi; Kanae Ogawa; Ayana Shirakami; Yi Shang; Chizuru Tsuruoka; Mayumi Nishimura; Yoshiya Shimada
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

3.  Analysis of copy number variations induced by ultrashort electron beam radiation in human leukocytes in vitro.

Authors:  Tigran Harutyunyan; Galina Hovhannisyan; Anzhela Sargsyan; Bagrat Grigoryan; Ahmed H Al-Rikabi; Anja Weise; Thomas Liehr; Rouben Aroutiounian
Journal:  Mol Cytogenet       Date:  2019-05-16       Impact factor: 2.009

Review 4.  DNA Copy Number Variations as Markers of Mutagenic Impact.

Authors:  Galina Hovhannisyan; Tigran Harutyunyan; Rouben Aroutiounian; Thomas Liehr
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

5.  Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident.

Authors:  Michael Abend; Ruth M Pfeiffer; Christian Ruf; Maureen Hatch; Tetiana I Bogdanova; Mykola D Tronko; Armin Riecke; Julia Hartmann; Viktor Meineke; Houda Boukheris; Alice J Sigurdson; Kiyohiko Mabuchi; Alina V Brenner
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

6.  Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers.

Authors:  M Abend; R M Pfeiffer; C Ruf; M Hatch; T I Bogdanova; M D Tronko; J Hartmann; V Meineke; K Mabuchi; A V Brenner
Journal:  Br J Cancer       Date:  2013-09-17       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.